Home
THTX
THTX News

Latest Theratechnologies Inc. (THTX) News on November 17, 2024

Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIV

GlobeNewswire

a month ago

Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIV

MT Newswires

a month ago

Theratechnologies Unveils Study Design of PROMISE-US Trial of Ibalizumab

Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance

GlobeNewswire

a month ago

Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance

Theratechnologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a month ago

Theratechnologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Theratechnologies Inc (THTX) Q3 2024 Earnings Call Highlights: Strong Profitability Amid ...

GuruFocus.com

a month ago

Theratechnologies Inc (THTX) Q3 2024 Earnings Call Highlights: Strong Profitability Amid ...

MT Newswires

a month ago

Theratechnologies Up 12% in U.S. Premarket Trading After Reporting Q3 Swing to Profit

Associated Press Finance

a month ago

Theratechnologies: Fiscal Q3 Earnings Snapshot

Theratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024

GlobeNewswire

a month ago

Theratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024

Earnings to Watch: Theratechnologies Inc (TSX:TH) Reports Q3 2024 Result

GuruFocus.com

a month ago

Earnings to Watch: Theratechnologies Inc (TSX:TH) Reports Q3 2024 Result

MT Newswires

a month ago

Theratechnologies to Present Data Next Week Highlighting Advances in Treatment in People with HIV

Theratechnologies to Present Data at IDWeek 2024 Highlighting Advances in Treatment and Management of Complications in People with HIV

GlobeNewswire

a month ago

Theratechnologies to Present Data at IDWeek 2024 Highlighting Advances in Treatment and Management of Complications in People with HIV

Theratechnologies to Announce Third Quarter 2024 Financial Results and Provide Business Update

GlobeNewswire

2 months ago

Theratechnologies to Announce Third Quarter 2024 Financial Results and Provide Business Update

Theratechnologies Faces Potential Supply Disruption For Its Top Selling Drug, Warns of Revenue Impact Due To Manufacturing Delays

Benzinga

2 months ago

Theratechnologies Faces Potential Supply Disruption For Its Top Selling Drug, Warns of Revenue Impact Due To Manufacturing Delays

MT Newswires

2 months ago

Theratechnologies Warns of Egrifta SV Supply Shortage After Shutdown at Contract Manufacturer's Facility

MT Newswires

2 months ago

Theratechnologies Sees Risk of Supply Disruption for Its EGRIFTA SV Drug in Early 2025

Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025

GlobeNewswire

2 months ago

Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025

Theratechnologies to Present at Upcoming Investor Conferences in September

GlobeNewswire

2 months ago

Theratechnologies to Present at Upcoming Investor Conferences in September

Positive Signs As Multiple Insiders Buy Theratechnologies Stock

Simply Wall St.

3 months ago

Positive Signs As Multiple Insiders Buy Theratechnologies Stock

Why Fast-paced Mover Theratechnologies (THTX) Is a Great Choice for Value Investors

Zacks

4 months ago

Why Fast-paced Mover Theratechnologies (THTX) Is a Great Choice for Value Investors

Theratechnologies Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

4 months ago

Theratechnologies Second Quarter 2024 Earnings: Beats Expectations

Despite Fast-paced Momentum, Theratechnologies (THTX) Is Still a Bargain Stock

Zacks

4 months ago

Despite Fast-paced Momentum, Theratechnologies (THTX) Is Still a Bargain Stock

HIV Medicine Maker Theratechnologies 'Wraps Up Strong Second Quarter,' Stock Soars

Benzinga

4 months ago

HIV Medicine Maker Theratechnologies 'Wraps Up Strong Second Quarter,' Stock Soars

Associated Press Finance

4 months ago

Theratechnologies: Fiscal Q2 Earnings Snapshot

MT Newswires

4 months ago

Theratechnologies Swings to Q2 Profit as Revenue Rises 25%; Confirms FY24 Guidance

Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024

GlobeNewswire

4 months ago

Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024

Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update

GlobeNewswire

5 months ago

Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update

Theratechnologies Inc. (TSE:TH) Has Found A Path To Profitability

Simply Wall St.

5 months ago

Theratechnologies Inc. (TSE:TH) Has Found A Path To Profitability

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

Yahoo Finance Video

5 months ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

GlobeNewswire

5 months ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

Reuters

5 months ago

California seeks company profits in Big Oil climate lawsuit

USA TODAY

5 months ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

GlobeNewswire

5 months ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

5 months ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Business Wire

5 months ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

GlobeNewswire

5 months ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Theratechnologies (THTX) Is Attractively Priced Despite Fast-paced Momentum

Zacks

5 months ago

Theratechnologies (THTX) Is Attractively Priced Despite Fast-paced Momentum

MT Newswires

6 months ago

Theratechnologies Up Near 5% In US After Hours On Data Related To Its Lead Investigational Peptide Drug Conjugate Candidate

GlobeNewswire

6 months ago

Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Theratechnologies Reports on its Annual Meeting of Shareholders

GlobeNewswire

6 months ago

Theratechnologies Reports on its Annual Meeting of Shareholders

Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting

GlobeNewswire

7 months ago

Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting

Theratechnologies (THTX) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

7 months ago

Theratechnologies (THTX) Upgraded to Buy: What Does It Mean for the Stock?

Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders

GlobeNewswire

7 months ago

Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders

Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

GlobeNewswire

7 months ago

Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Associated Press Finance

7 months ago

Theratechnologies: Fiscal Q1 Earnings Snapshot

Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024

GlobeNewswire

7 months ago

Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024

Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology Platform

GlobeNewswire

7 months ago

Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology Platform

Theratechnologies Appoints Elina Tea to its Board of Directors

GlobeNewswire

7 months ago

Theratechnologies Appoints Elina Tea to its Board of Directors

Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business Update

GlobeNewswire

7 months ago

Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business Update

Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ Platform

GlobeNewswire

8 months ago

Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ Platform

Theratechnologies Announces Update on its Preclinical Oncology Research Program

GlobeNewswire

8 months ago

Theratechnologies Announces Update on its Preclinical Oncology Research Program

Theratechnologies Appoints Jordan Zwick to its Board of Directors

GlobeNewswire

8 months ago

Theratechnologies Appoints Jordan Zwick to its Board of Directors

Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer

GlobeNewswire

8 months ago

Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer

Theratechnologies Announces the Resignation of One of Its Directors, Mr. Alain Trudeau

GlobeNewswire

9 months ago

Theratechnologies Announces the Resignation of One of Its Directors, Mr. Alain Trudeau

Theratechnologies Receives Refusal to File Letter for Trogarzo® Intramuscular Method of Administration sBLA from FDA

GlobeNewswire

9 months ago

Theratechnologies Receives Refusal to File Letter for Trogarzo® Intramuscular Method of Administration sBLA from FDA

Theratechnologies (THTX) Shows Fast-paced Momentum But Is Still a Bargain Stock

Zacks

9 months ago

Theratechnologies (THTX) Shows Fast-paced Momentum But Is Still a Bargain Stock

Theratechnologies Full Year 2023 Earnings: Misses Expectations

Simply Wall St.

9 months ago

Theratechnologies Full Year 2023 Earnings: Misses Expectations

Associated Press Finance

9 months ago

Theratechnologies: Fiscal Q4 Earnings Snapshot

Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance

GlobeNewswire

9 months ago

Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance

Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of Action

GlobeNewswire

9 months ago

Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of Action

Theratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer

GlobeNewswire

9 months ago

Theratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer

Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update

GlobeNewswire

9 months ago

Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update

Positive Signs As Multiple Insiders Buy Theratechnologies Stock

Simply Wall St.

10 months ago

Positive Signs As Multiple Insiders Buy Theratechnologies Stock

Business Wire

10 months ago

ClearBridge MLP Funds Announce Proposed Mergers and Updates for Tender Offers

Associated Press Finance

10 months ago

Northrim: Q4 Earnings Snapshot

Northrim BanCorp Earns $6.6 million, or $1.19 Per Diluted Share, in Fourth Quarter 2023, and $25.4 Million, or $4.49 Per Diluted Share, for the Year Ended December 31, 2023

GlobeNewswire

10 months ago

Northrim BanCorp Earns $6.6 million, or $1.19 Per Diluted Share, in Fourth Quarter 2023, and $25.4 Million, or $4.49 Per Diluted Share, for the Year Ended December 31, 2023

What Makes AirSculpt Technologies, Inc. (AIRS) a New Strong Buy Stock

Zacks

10 months ago

What Makes AirSculpt Technologies, Inc. (AIRS) a New Strong Buy Stock

Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLA

GlobeNewswire

10 months ago

Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLA

Theratechnologies Receives Update from FDA on Tesamorelin F8 Supplemental Biologic License Application

GlobeNewswire

10 months ago

Theratechnologies Receives Update from FDA on Tesamorelin F8 Supplemental Biologic License Application

Gap (NYSE:GPS) Q3 Earnings: Leading The Apparel Retailer Pack

StockStory

10 months ago

Gap (NYSE:GPS) Q3 Earnings: Leading The Apparel Retailer Pack

Business Wire

10 months ago

First Trust High Income Long/Short Fund Declares its Monthly Common Share Distribution of $0.105 Per Share for February

CCSC Technology International Holdings Limited Announces Closing of Initial Public Offering

GlobeNewswire

10 months ago

CCSC Technology International Holdings Limited Announces Closing of Initial Public Offering

Strength Seen in Viant (DSP): Can Its 9.0% Jump Turn into More Strength?

Zacks

10 months ago

Strength Seen in Viant (DSP): Can Its 9.0% Jump Turn into More Strength?

Business Wire

10 months ago

Franklin Templeton Fund Adviser, LLC Announces Distributions for the Month of February 2024

The RMR Group Inc's Dividend Analysis

GuruFocus.com

10 months ago

The RMR Group Inc's Dividend Analysis

PodcastOne (Nasdaq: PODC) Renews Agreement With Award Winning Our Fake History Podcast

GlobeNewswire

10 months ago

PodcastOne (Nasdaq: PODC) Renews Agreement With Award Winning Our Fake History Podcast

We Think Applied Therapeutics (NASDAQ:APLT) Needs To Drive Business Growth Carefully

Simply Wall St.

10 months ago

We Think Applied Therapeutics (NASDAQ:APLT) Needs To Drive Business Growth Carefully

Asensus Surgical Announces Nagoya University Hospital in Japan to Initiate Senhance Surgery Program

GlobeNewswire

10 months ago

Asensus Surgical Announces Nagoya University Hospital in Japan to Initiate Senhance Surgery Program

The past three years for Nexxen International (LON:NEXN) investors has not been profitable

Simply Wall St.

10 months ago

The past three years for Nexxen International (LON:NEXN) investors has not been profitable

Pixie Dust Technologies, Inc. Introduces Additional Pricing Option for Proprietary Speaker kikippa

PR Newswire

10 months ago

Pixie Dust Technologies, Inc. Introduces Additional Pricing Option for Proprietary Speaker kikippa

Nexxen to Present at the Needham Growth Conference

GlobeNewswire

10 months ago

Nexxen to Present at the Needham Growth Conference

Bit Digital, Inc. Announces Upsized Customer Contract for Bit Digital AI

PR Newswire

10 months ago

Bit Digital, Inc. Announces Upsized Customer Contract for Bit Digital AI

Arqit announces reseller agreement with Phalanx

GlobeNewswire

10 months ago

Arqit announces reseller agreement with Phalanx

Sangoma Named In The 2023 Gartner® Magic Quadrant™ For Unified Communications As A Service Report For Ninth Year

Business Wire

10 months ago

Sangoma Named In The 2023 Gartner® Magic Quadrant™ For Unified Communications As A Service Report For Ninth Year

Business Wire

10 months ago

ClearBridge Energy Midstream Opportunity Fund Inc. Announces Unaudited Balance Sheet Information as of December 31, 2023

Mural Oncology Announces Enhancements to Late-Stage Clinical Trials

GlobeNewswire

10 months ago

Mural Oncology Announces Enhancements to Late-Stage Clinical Trials

Amundi US Declares Monthly Distributions for Pioneer Closed-End Funds

Business Wire

10 months ago

Amundi US Declares Monthly Distributions for Pioneer Closed-End Funds

Strength Seen in Collegium Pharmaceutical (COLL): Can Its 8.4% Jump Turn into More Strength?

Zacks

10 months ago

Strength Seen in Collegium Pharmaceutical (COLL): Can Its 8.4% Jump Turn into More Strength?

Electrovaya Announces Date for Q4 FY-2023 and FY-2023 Financial Results and Conference Call

ACCESSWIRE

10 months ago

Electrovaya Announces Date for Q4 FY-2023 and FY-2023 Financial Results and Conference Call

Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDA

GlobeNewswire

10 months ago

Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDA

First Trust High Income Long/Short Fund's Dividend Analysis

GuruFocus.com

a year ago

First Trust High Income Long/Short Fund's Dividend Analysis

Business Wire

a year ago

ClearBridge MLP and Midstream Fund Inc., ClearBridge Energy Midstream Opportunity Fund Inc. and ClearBridge MLP and Midstream Fund Total Return Inc. Announce Plans for Tender Offers

Theratechnologies Announces Renewal of Shelf Prospectus and Filing of Registration Statement

PR Newswire

a year ago

Theratechnologies Announces Renewal of Shelf Prospectus and Filing of Registration Statement

Theratechnologies Announces Renewal of Shelf Prospectus and Filing of Registration Statement

CNW Group

a year ago

Theratechnologies Announces Renewal of Shelf Prospectus and Filing of Registration Statement

Ocugen Gains FDA Alignment on Key Aspects of OCU400—Modifier Gene Therapy—Pivotal Phase 3 Study Design

GlobeNewswire

a year ago

Ocugen Gains FDA Alignment on Key Aspects of OCU400—Modifier Gene Therapy—Pivotal Phase 3 Study Design

Business Wire

a year ago

First Trust High Income Long/Short Fund Declares its Monthly Common Share Distribution of $0.105 Per Share for January

Eos Energy Announces Launch of Proposed $40M Public Offering

GlobeNewswire

a year ago

Eos Energy Announces Launch of Proposed $40M Public Offering

Institutional investors in Root, Inc. (NASDAQ:ROOT) lost 14% last week but have reaped the benefits of longer-term growth

Simply Wall St.

a year ago

Institutional investors in Root, Inc. (NASDAQ:ROOT) lost 14% last week but have reaped the benefits of longer-term growth

Theratechnologies Announces FDA Approval of Trogarzo® 90-Second Intravenous (IV) Push Loading Dose

GlobeNewswire

a year ago

Theratechnologies Announces FDA Approval of Trogarzo® 90-Second Intravenous (IV) Push Loading Dose

BioXcel Therapeutics Hosting Virtual Neuroscience R&D Day Today

GlobeNewswire

a year ago

BioXcel Therapeutics Hosting Virtual Neuroscience R&D Day Today

Business Wire

a year ago

ClearBridge Energy Midstream Opportunity Fund Inc. Announces Unaudited Balance Sheet Information as of November 30, 2023

Share on Social Networks: